Do antibody CDR loops change conformation upon binding?
Antibodies have increasingly been developed as drugs with over 100 now licensed in the US or EU. During development, it is often necessary to increase or reduce the affinity of an antibody and rational attempts to do so rely on having a structure of the antibody-antigen complex often obtained by mod...
Saved in:
Main Authors: | Chu’nan Liu, Lilian M. Denzler, Oliver E.C. Hood, Andrew C.R. Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2024.2322533 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structure- and machine learning-guided engineering demonstrate that a non-canonical disulfide in an anti-PD-1 rabbit antibody does not impede antibody developability
by: Wei-Ching Liang, et al.
Published: (2024-12-01) -
Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01) -
Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challenge
by: M. Biddle, et al.
Published: (2024-12-01) -
Synthetic integrin antibodies discovered by yeast display reveal αV subunit pairing preferences with β subunits
by: Yuxin Hao, et al.
Published: (2024-12-01) -
Understanding the impacts of dual methionine oxidations in complementarity-determining regions on the structure of monoclonal antibodies
by: Bo Zhao, et al.
Published: (2024-12-01)